Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021)

Agios Pharmaceuticals' Divestments history spans 2 years, with the latest figure at $1.8 billion for Q1 2021.

  • For Q1 2021, Divestments rose 695080.69% year-over-year to $1.8 billion; the TTM value through Mar 2022 reached -$455000.0, down 100.03%, while the annual FY2024 figure was $200.0 million, N/A changed from the prior year.
  • Divestments reached $1.8 billion in Q1 2021 per AGIO's latest filing, up from -$455000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $1.8 billion in Q1 2021 to a low of -$455000.0 in Q4 2020.